Literature DB >> 3947747

Effect of acidic and basic isoferritins on in vitro growth of human granulocyte-monocyte progenitors.

L Dezza, M Cazzola, W Piacibello, P Arosio, S Levi, M Aglietta.   

Abstract

Acidic isoferritins have been previously found to be highly potent inhibitors of hematopoietic progenitors at concentrations of 10(-16) to 10(-18) mol/L, and it has been suggested that acidic isoferritin inhibitory activity plays a role in the regulation of normal hematopoiesis and also in the pathogenesis of leukemia. To characterize the ferritin species that affect the in vitro growth of human colony-forming unit-granulocyte-macrophage (CFU-GM), we tested different preparations of basic (L-subunit-rich) and acidic (H-subunit-rich) isoferritins. Three preparations of human liver (basic) ferritin did not show any effects on CFU-GM growth at concentrations up to 10(-9) mol/L, irrespective of the degree of glycosylation. Acidic isoferritins were purified both from HeLa cells and human heart. HeLa cell ferritin did not affect in vitro colony formation. One of two preparations of human heart ferritin, containing 5% glycosylated ferritin, showed a mean inhibition of 26% +/- 8% of the control at 10(-9) mol/L (P less than .02), whereas the other preparation, which contained no glycosylated ferritin, did not show any effect of CFU-GM growth. A preparation enriched for glycosylated acidic isoferritins from human heart was found to produce a mean inhibition of 32% +/- 11% of the control at 10(-9) mol/L (P less than .01), whereas another one was ineffective. A significant part of the inhibitory activity was removed by preincubation with the monoclonal antibody 2A4 directed against human heart ferritin. The present findings indicate that basic isoferritins, ie, the predominant ferritin type in human blood, have no effect on the growth of human CFU-GM, and this is in keeping with indirect clinical evidence. Inhibition of colony formation may be obtained by some preparations of acidic isoferritins that are rich in H subunits and bind to concanavalin A. The mechanism(s) responsible for this are not clear, but the effective concentrations are higher than those found in human blood both under normal conditions and in leukemia. At present, the physiologic significance of the observed inhibitory activity is uncertain.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3947747

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  5 in total

1.  Duodenal iron proteins in idiopathic hemochromatosis.

Authors:  P Whittaker; B S Skikne; A M Covell; C Flowers; A Cooke; S R Lynch; J D Cook
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

2.  Identification and characterization of a receptor for tissue ferritin on activated rat lipocytes.

Authors:  G A Ramm; R S Britton; R O'Neill; B R Bacon
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

3.  Ferritin stimulation of a monokine inhibitor of lipopolysaccharide-augmented myelopoiesis is ferroxidase dependent.

Authors:  R Kreisberg; H E Broxmeyer; R N Moore
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

4.  Neutralization of inhibitory activity derived from cells of MDS patients and ML-2 cell line by monoclonal antibodies against H and L-subunit-rich ferritins.

Authors:  V Cukrová; R Neuwirtová
Journal:  Blut       Date:  1990-11

5.  Mutated recombinant human heavy-chain ferritins and myelosuppression in vitro and in vivo: a link between ferritin ferroxidase activity and biological function.

Authors:  H E Broxmeyer; S Cooper; S Levi; P Arosio
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.